The use of cimetropii bromidum as premedication for endoscopy of the upper gastro-intestinal tract: a double-blind controlled clinical trial.
J Int Med Res
; 13(6): 332-7, 1985.
Article
in En
| MEDLINE
| ID: mdl-4076532
ABSTRACT
The effectiveness of cimetropii bromidum (10 or 20 mg i.v.) as premedication for upper gastro-intestinal tract endoscopy was examined and compared with that of placebo in a double-blind crossover study involving 160 patients. The drug effects were assessed from the degree of opening of the pyloric sphincter and the endoscopist's rating of drug performance. The study showed that the effects of cimetropii bromidum differed highly significantly (p less than 0.0001) from those of placebo, on either count. No adverse effects were noted.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parasympatholytics
/
Scopolamine Derivatives
/
Duodenal Ulcer
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Int Med Res
Year:
1985
Document type:
Article